- Home
- BANX vs INO Comparison
BANX vs INO Comparison
Compare BANX & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANX
- INO
- Stock Information
- Founded
- BANX 2013
- INO 1979
- Country
- BANX United States
- INO United States
- Employees
- BANX N/A
- INO N/A
- Industry
- BANX Trusts Except Educational Religious and Charitable
- INO Medical/Dental Instruments
- Sector
- BANX Finance
- INO Health Care
- Exchange
- BANX Nasdaq
- INO Nasdaq
- Market Cap
- BANX 146.9M
- INO 136.6M
- IPO Year
- BANX N/A
- INO 1998
- Fundamental
- Price
- BANX $21.05
- INO $2.26
- Analyst Decision
- BANX
- INO Buy
- Analyst Count
- BANX 0
- INO 5
- Target Price
- BANX N/A
- INO $8.80
- AVG Volume (30 Days)
- BANX 23.4K
- INO 1.1M
- Earning Date
- BANX 06-17-2025
- INO 11-10-2025
- Dividend Yield
- BANX 9.66%
- INO N/A
- EPS Growth
- BANX N/A
- INO N/A
- EPS
- BANX 2.35
- INO N/A
- Revenue
- BANX $29,467,794.00
- INO $182,337.00
- Revenue This Year
- BANX N/A
- INO N/A
- Revenue Next Year
- BANX N/A
- INO $14,751.49
- P/E Ratio
- BANX $8.88
- INO N/A
- Revenue Growth
- BANX 2.73
- INO N/A
- 52 Week Low
- BANX $17.99
- INO $1.30
- 52 Week High
- BANX $21.67
- INO $5.80
- Technical
- Relative Strength Index (RSI)
- BANX 37.34
- INO 44.47
- Support Level
- BANX $21.00
- INO $2.29
- Resistance Level
- BANX $21.34
- INO $2.58
- Average True Range (ATR)
- BANX 0.27
- INO 0.15
- MACD
- BANX -0.07
- INO -0.02
- Stochastic Oscillator
- BANX 2.12
- INO 10.75
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.